Features of alpha-synuclein that could explain the progression and irreversibility of Parkinson's disease
- PMID: 25805964
- PMCID: PMC4353246
- DOI: 10.3389/fnins.2015.00059
Features of alpha-synuclein that could explain the progression and irreversibility of Parkinson's disease
Abstract
Alpha-synuclein is a presynaptic protein expressed throughout the central nervous system, and it is the main component of Lewy bodies, one of the histopathological features of Parkinson's disease (PD) which is a progressive and irreversible neurodegenerative disorder. The conformational flexibility of α-synuclein allows it to adopt different conformations, i.e., bound to membranes or form aggregates, the oligomers are believed to be the more toxic species. In this review, we will focus on two major features of α-synuclein, transmission and toxicity, that could help to understand the pathological characteristics of PD. One important feature of α-synuclein is its ability to be transmitted from neuron to neuron using mechanisms such as endocytosis, plasma membrane penetration or through exosomes, thus propagating the Lewy body pathology to different brain regions thereby contributing to the progressiveness of PD. The second feature of α-synuclein is that it confers cytotoxicity to recipient cells, principally when it is in an oligomeric state. This form causes mitochondrial dysfunction, endoplasmic reticulum stress, oxidative stress, proteasome impairment, disruption of plasma membrane and pore formation that lead to apoptosis pathway activation and consequent cell death. The complexity of α-synuclein oligomerization and formation of toxic species could be a major factor for the irreversibility of PD and could also explain the lack of successful therapies to halt the disease.
Keywords: Parkinson's disease; alpha-synuclein; neurodegeneration; toxicity; transmission.
Figures



Similar articles
-
Induction of α-synuclein aggregate formation by CSF exosomes from patients with Parkinson's disease and dementia with Lewy bodies.Brain. 2016 Feb;139(Pt 2):481-94. doi: 10.1093/brain/awv346. Epub 2015 Dec 8. Brain. 2016. PMID: 26647156 Free PMC article.
-
Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder?Mov Disord. 2013 Jan;28(1):31-40. doi: 10.1002/mds.25373. Mov Disord. 2013. PMID: 23390095 Review.
-
α-Synuclein pathology in Parkinson's disease and related α-synucleinopathies.Neurosci Lett. 2019 Sep 14;709:134316. doi: 10.1016/j.neulet.2019.134316. Epub 2019 Jun 3. Neurosci Lett. 2019. PMID: 31170426 Free PMC article. Review.
-
Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases.Neuromolecular Med. 2003;4(1-2):21-36. doi: 10.1385/NMM:4:1-2:21. Neuromolecular Med. 2003. PMID: 14528050 Review.
-
Is Cell Death Primary or Secondary in the Pathophysiology of Idiopathic Parkinson's Disease?Biomolecules. 2015 Jul 16;5(3):1467-79. doi: 10.3390/biom5031467. Biomolecules. 2015. PMID: 26193328 Free PMC article. Review.
Cited by
-
Association between carotid plaque and Parkinson's disease.Ann Transl Med. 2019 Mar;7(5):94. doi: 10.21037/atm.2019.01.68. Ann Transl Med. 2019. PMID: 31019944 Free PMC article.
-
Dopamine-dependent early synaptic and motor dysfunctions induced by α-synuclein in the nigrostriatal circuit.Brain. 2021 Dec 16;144(11):3477-3491. doi: 10.1093/brain/awab242. Brain. 2021. PMID: 34297092 Free PMC article.
-
Deregulation of α-synuclein in Parkinson's disease: Insight from epigenetic structure and transcriptional regulation of SNCA.Prog Neurobiol. 2017 Jul;154:21-36. doi: 10.1016/j.pneurobio.2017.04.004. Epub 2017 Apr 23. Prog Neurobiol. 2017. PMID: 28445713 Free PMC article. Review.
-
Dynamics of a model for the degradation mechanism of aggregated α-synuclein in Parkinson's disease.Front Comput Neurosci. 2023 Apr 13;17:1068150. doi: 10.3389/fncom.2023.1068150. eCollection 2023. Front Comput Neurosci. 2023. PMID: 37122994 Free PMC article.
-
Exploring the link between Parkinson's disease and type 2 diabetes mellitus in Drosophila.FASEB J. 2022 Aug;36(8):e22432. doi: 10.1096/fj.202200286R. FASEB J. 2022. PMID: 35766235 Free PMC article.
References
-
- Aguayo L. G., Parodi J., Sepúlveda F. J., Opazo C. (2009). Pore-forming neurotoxin-like mechanism for Aβ oligomer-induced synaptic failure, in Pore-Forming Neurotoxin-Like Mechanism for Aβ Oligomer-Induced Synaptic Failure, eds Perry G., Maccioni R. B. (New York, NY: Springer; ), 13–21 10.1007/978-0-387-87995-6 - DOI
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases